Mary Kerr CEO NeRRe Therapeutics guest speaker at a recent Labiotech meeting in London
Mary Kerr CEO NeRRe Therapeutics guest speaker at a recent Labiotech meeting in London
Mary Kerr CEO NeRRe Therapeutics guest speaker at a recent Labiotech meeting in London
NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.